Login / Signup

Pelvic Floor Dysfunction in Transgender Men on Gender-affirming Hormone Therapy: A Descriptive Cross-sectional Study.

Lyvia Maria Bezerra da SilvaSilvana Neves Dias FreireEduarda MorettiLeila Maria Álvares Barbosa
Published in: International urogynecology journal (2024)
Transgender men on hormone therapy have a high incidence of PFD (94.1%) and experience a greater occurrence of urinary symptoms (86.7%).
Keyphrases
  • risk assessment
  • middle aged
  • hiv testing
  • risk factors
  • oxidative stress
  • cross sectional
  • bone marrow
  • men who have sex with men
  • hiv infected
  • human immunodeficiency virus